Immunocompromised patients and COVID infections: Who's at risk? medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Who's at Risk? Immunocompromised Patients and COVID Infections miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
<p>A prospective study published in the journal <em>Lancet Microbe</em> provides more clarity on which patient populations are at higher risk for prolonged COVID infections.</p>
Letermovir was shown to be just as effective as valganciclovir in preventing CMV in kidney transplant recipients in new study published in JAMA; results prompt additional FDA approval for this indication.